Nurse Practitioner, Family · New York, NY
NPI
1437589215
Since 2013
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
6
Medicare group memberships
Hospitals
0
Hospital affiliations
160 E 53rd St
New York, NY, 10022
Phone (347) 798-9013
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
6,051 services
Medicare patients, 2024
23
Average age 69
Drug cost, 2024
$288K
233 prescriptions
Company payments, 2025
$1,799
From 23 companies
Medicare prescription drug claims, 2024
In 2024, the drug Naomi Torres prescribed most often to Medicare patients was Tamsulosin Hcl, with 45 prescriptions and refills. In total Naomi Torres wrote 233 Medicare prescriptions that cost $288K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-14.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Tamsulosin Hcl Generic | 45 | 58 | 20 | $395 |
| Finasteride Generic | 27 | 36 | Under 11 | $119 |
| Xiaflex Collagenase Clostridium Hist. | 22 | 31 | Under 11 | $271K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 15 | 26 | Under 11 | $223 |
| Naproxen Generic | 14 | 14 | 12 | $14.12 |
Brand drugs: 41 claims; generic drugs: 192 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Naomi Torres $1,799 ($1,799 in general payments such as food, travel and fees) from 23 companies. The largest payer was Astellas Pharma US Inc with $391.
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc 4503.T | 8 | $391 |
| Seagen Inc. PFE | 2 | $174 |
| Tactile Systems Technology Inc TCMD | 2 | $144 |
| Daiichi Sankyo Inc. 4568.T | 1 | $125 |
| Janssen Biotech, Inc. JNJ | 5 | $122 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $102 |
| Eisai Inc. 4523.T | 4 | $88.58 |
| Merck Sharp & Dohme LLC MRK | 3 | $71.61 |
| Taiho Oncology, Inc. 4578.T | 3 | $65.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.